E. Hawk, P. Linburg, and J. Viner, Epidemiology and prevention of colorectal cancer, Surgical Clinics of North America, vol.82, issue.5, pp.905-941, 2002.
DOI : 10.1016/S0039-6109(02)00046-4

A. Jemal, F. Bray, M. Center, J. Ferlay, E. Ward et al., Global cancer statistics, Global cancer statistics, pp.69-90, 2011.
DOI : 10.3322/caac.20107

B. Vogelstein, E. Fearon, S. Hamilton, S. Kern, A. Preisinger et al., Genetic Alterations during Colorectal-Tumor Development, New England Journal of Medicine, vol.319, issue.9, pp.525-532, 1988.
DOI : 10.1056/NEJM198809013190901

J. Jass, Classification of colorectal cancer based on correlation of clinical, morphological and molecular features, Histopathology, vol.154, issue.1, pp.113-130, 2007.
DOI : 10.1084/jem.184.3.1075

A. Levine, p53, the Cellular Gatekeeper for Growth and Division, Cell, vol.88, issue.3, pp.23-331, 1997.
DOI : 10.1016/S0092-8674(00)81871-1

B. Iacopeta, TP53 mutation in colorectal cancer, Human Mutation, vol.12, issue.3, pp.271-276, 2003.
DOI : 10.1002/humu.10175

T. Soussi, TP53 Mutations in Human Cancer: Database Reassessment and Prospects for the Next Decade, Adv Cancer Res, vol.110, pp.107-139, 2011.
DOI : 10.1016/B978-0-12-386469-7.00005-0

T. Riley, E. Sontag, P. Chen, and A. Levine, Transcriptional control of human p53-regulated genes, Nature Reviews Molecular Cell Biology, vol.18, issue.5, pp.402-412, 2008.
DOI : 10.1038/nrm2395

J. Gannon, R. Greaves, R. Iggo, and D. Lane, Activating mutations in p53 produce a common conformational effect: a monoclonal antibody specific for the mutant form, EMBO J, vol.9, pp.1595-1602, 1990.

B. Kerns, P. Jordan, M. Moore, P. Humphrey, A. Berchuck et al., p53 overexpression in formalin-fixed, paraffin-embedded tissue detected by immunohistochemistry., Journal of Histochemistry & Cytochemistry, vol.40, issue.7, pp.1047-1051, 1992.
DOI : 10.1177/40.7.1607637

D. Serra, L. Chérié-challine, and J. Bloch, Cancer mortality in French West Indies and French metropolitan regions, France, pp.64-88, 1983.

P. Ngasseu, M. Dieye, J. Veronique-baudin, C. Draganescu, M. Dorival et al., Cancers colorectaux en??Martinique: incidence et??mortalit?? durant??une??p??riode de??20??ans, Revue d'??pid??miologie et de Sant?? Publique, vol.55, issue.5, pp.333-338, 2007.
DOI : 10.1016/j.respe.2007.06.001

M. Dieye, J. Veronique-baudin, C. Draganescu, and H. Azaloux, Cancer incidence in Martinique: a model of epidemiological transition, European Journal of Cancer Prevention, vol.16, issue.2, pp.95-101, 2007.
DOI : 10.1097/01.cej.0000236246.78736.51

L. Keclard, R. M. Saint-martin, and C. , Epidémiology des gènes globines dans le bassin caribéen In La drépanocytose -Regards croisés sur une maladie orpheline, Edited by Karthala, pp.75-91, 2004.

R. Wong, Proximal Tumors Are Associated with Greater Mortality in Colon Cancer, Journal of General Internal Medicine, vol.54, issue.11, pp.1157-1163, 2010.
DOI : 10.1007/s11606-010-1460-4

N. Bossai, M. Velten, and L. Remontet, Survival of cancer patients in France: a population based study from the association of the French cancer registry (FRANCIM), Eur J Cancer, vol.43, pp.149-156, 2007.

K. Chevreul, Colorectal cancer in France, The European Journal of Health Economics, vol.9, issue.S1, pp.15-20, 2010.
DOI : 10.1007/s10198-009-0185-y

V. Katkoon, X. Jia, C. Shnmugam, W. Wan, S. Meleth et al., Prognostic Significance of p53 Codon 72 Polymorphism Differs with Race in Colorectal Adenocarcinoma, Clinical Cancer Research, vol.15, issue.7, pp.2406-2416, 2009.
DOI : 10.1158/1078-0432.CCR-08-1719

B. Polite, J. Dignam, and O. Olopade, Colorectal Cancer Model of Health Disparities: Understanding Mortality Differences in Minority Populations, Journal of Clinical Oncology, vol.24, issue.14, pp.2179-2187, 2006.
DOI : 10.1200/JCO.2005.05.4775

B. Polite, J. Dignam, and O. Olopade, Colorectal Cancer and Race: Understanding the Differences in Outcomes Between African Americans and Whites, Medical Clinics of North America, vol.89, issue.4, pp.771-793, 2005.
DOI : 10.1016/j.mcna.2005.03.001

N. Loconte, A. Williamson, A. Gayle, J. Weiss, T. Leal et al., Increasing disparity in colorectal cancer incidence http://www.biomedcentral.com/1472-6890/14/12 and mortality among African Americans and Whites: a state's Experience, J Gastro intest Oncol, vol.2, pp.85-92, 2011.

P. Chalya, M. Mchembe, J. Mabula, P. Rambau, H. Jaka et al., Clinicopathological patterns and challenges of management of colorectal cancer in a resource-limited setting: a Tanzanian experience, World Journal of Surgical Oncology, vol.11, issue.1, pp.10-1186, 2013.
DOI : 10.1007/s10350-007-0228-3

D. Lane, p53, guardian of the genome, Nature, vol.358, issue.6381, pp.15-16, 1992.
DOI : 10.1038/358015a0

P. Rambau, M. Odida, and H. Wabinga, expression in colorectal carcinoma in relation to histopathological features in Ugandan patients, Afr Health Sci, vol.8, pp.53234-238, 2008.

H. Kwon, S. Kim, S. Oh, S. Lee, K. Kwon et al., Clinicopathological significance of p53, hypoxia-inducible factor 1alpha, and vascular endothelial growth factor expression in colorectal cancer, Anticancer Res, vol.30, pp.4163-4168, 2010.

G. Galizia, E. Lieto, F. Ferraraccio, M. Orditura, D. Vita et al., Determination of Molecular Marker Expression Can Predict Clinical Outcome in Colon Carcinomas, Clinical Cancer Research, vol.10, issue.10, pp.3490-3499, 2004.
DOI : 10.1158/1078-0432.CCR-0960-03

H. Lenz, K. Danenberg, C. Leichman, B. Florentine, P. Johnston et al., and thymidylate synthase expression in untreated stage II colon cancer: association with recurrence, survival and site, Clin Cancer Res, vol.4, pp.531227-1234, 1998.

U. Mane, H. Weiss, R. Myers, O. Danner, C. Moron et al., Nuclear accumulation of p53 in colorectal adenocarcinoma, Cancer, vol.3, issue.12, pp.2456-2457, 1998.
DOI : 10.1002/(SICI)1097-0142(19981215)83:12<2456::AID-CNCR8>3.0.CO;2-5

M. Diez, M. Medrano, J. Muguerza, P. Ramos, P. Hernandez et al., Influence of tumor localization on the prognostic value of p53 protein in colorectal adenocarcinomas, Anticancer Res, vol.20, pp.3907-3912, 2000.